During this internal meeting, apart from inspiring key note lectures, we will highlight the progress, achievements and new activities within HARMONY and HARMONY PLUS.
DATE/TIME: Thursday, 18 November 2021, starting at 12:00 CET | Friday, 19 November 2021, starting at 09:00 CET
REGISTRATION: HARMONY and HARMONY PLUS Community, to confirm your participation, please click here >
HOTELS: To accommodate your stay, find a selection of hotels in The Hague >
TRAVELING TO THE NETHERLANDS: Find an update of the COVID-19 regulations here >
VENUE ADDRESS: The Hague Conference Centre New Babylon, Anna van Buerenplein 29, 2595 DA The Hague (entrance 1), or Bezuidenhoutseweg (entrance 2). The venue is located next to The Hague Central Station.
Are you interested to become involved in HARMONY as an Associated Member, and would like to attend our General Assembly ? Send us an email >
The 6th HARMONY Alliance General Assembly is hosted by
More about the Municipality of The Hague: click here >
#BigDataforbloodcancer | Big Data accelerate better and faster treatment for Patients with Hematologic Malignancies
The HARMONY Alliance is a European Public–Private Partnership for Big Data in Hematology that is capturing and mining Big Data on various Hematologic Malignancies. The HARMONY Alliance, funded by Innovative Medicines Initiative, unites more than 100 organizations such as European medical associations, hospitals, research institutes, patient organizations, pharmaceutical and IT companies. HARMONY uses Big Data analytics to accelerate the development of more effective treatments for blood cancer patients. The aim is to accelerate the development of more effective treatments. Data are stored in HARMONY’s Big Data Platform, which has already identified over 80,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods.
Receive the latest news. Click here to subscribe!